Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
immunotoxin HA22
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT03501615
2020-06-29
MOXE
AstraZeneca
Approved for marketing